NCT00570050View on ClinicalTrials.gov

Effect of Intranasal Insulin on Depressive Symptoms in Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Major Depressive Disorder
Interventions
DRUG

Diluent / Insulin

Diluent (4 Weeks ) / Intranasal insulin (4 weeks)

DRUG

Insulin / Diluent

Intranasal Insulin (4 Weeks ) / Diluent (4 Weeks)

Trial Locations (1)

M5T 2S8

Toronto Western Hospital, Toronto

All Listed Sponsors
collaborator

McMaster University

OTHER

lead

University Health Network, Toronto

OTHER

NCT00570050 - Effect of Intranasal Insulin on Depressive Symptoms in Major Depressive Disorder | Biotech Hunter | Biotech Hunter